CCCC — C4 Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for C4 Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.5	372	309	276	254
Net Total Accounts Receivable
Net Total Receivables	4.62	4.48	5.72	1.47	11.8
Prepaid Expenses
Total Current Assets	96.8	381	326	288	271
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18.9	16.6	35.1	77.5	71.1
Long Term Investments
Other Long Term Assets
Total Assets	118	400	507	431	376
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	33.6	43.9	51.2	44.5	42.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	119	119	117	142	130
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.968	281	390	289	246
Total Liabilities & Shareholders' Equity	118	400	507	431	376
Total Common Shares Outstanding